BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 10, 2011
 |  BC Week In Review  |  Company News  |  Other News

Alnylam metabolic, hematology news

Alnylam launched its "Alnylam 5x15" strategy with the goal of moving five RNAi therapeutic programs into advanced clinical development by 2015. The most advanced of the five programs is ALN-TTR, which consists of...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >